Financial Consulate Inc. reduced its holdings in shares of Exelon Co. (NASDAQ:EXC) by 15.7% during the fourth quarter, HoldingsChannel reports. The firm owned 7,270 shares of the company’s stock after selling 1,359 shares during the period. Financial Consulate Inc.’s holdings in Exelon were worth $307,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently bought and sold shares of EXC. Summit X LLC purchased a new position in Exelon in the third quarter worth about $29,000. Advisory Alpha LLC bought a new position in shares of Exelon in the third quarter worth about $29,000. Fortis Group Advisors LLC bought a new position in shares of Exelon in the third quarter worth about $29,000. Mirova purchased a new stake in Exelon during the 3rd quarter valued at approximately $31,000. Finally, Kistler Tiffany Companies LLC raised its position in shares of Exelon by 88.1% during the third quarter. Kistler Tiffany Companies LLC now owns 918 shares of the company’s stock valued at $33,000 after buying an additional 430 shares during the last quarter. Institutional investors and hedge funds own 76.59% of the company’s stock.
Several research firms recently weighed in on EXC. Bank of America raised shares of Exelon from a “neutral” rating to a “buy” rating in a research note on Wednesday, January 6th. Credit Suisse Group increased their price target on Exelon from $44.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday, November 2nd. Argus lifted their price objective on Exelon from $42.00 to $45.00 and gave the stock a “buy” rating in a research note on Friday, December 11th. Guggenheim downgraded Exelon from a “buy” rating to a “neutral” rating and lowered their target price for the company from $46.00 to $42.00 in a research report on Monday, October 26th. Finally, Mizuho reduced their price target on shares of Exelon from $37.00 to $36.00 and set an “underperform” rating on the stock in a research report on Thursday, November 19th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and ten have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $45.00.
Shares of EXC stock traded up $0.66 during trading hours on Monday, reaching $42.22. 181,370 shares of the stock were exchanged, compared to its average volume of 5,015,890. The firm has a market capitalization of $41.19 billion, a price-to-earnings ratio of 17.37, a price-to-earnings-growth ratio of 5.31 and a beta of 0.41. Exelon Co. has a 12-month low of $29.28 and a 12-month high of $50.54. The company’s 50-day moving average price is $42.22 and its 200-day moving average price is $41.87. The company has a current ratio of 1.09, a quick ratio of 0.94 and a debt-to-equity ratio of 1.02.
Exelon (NASDAQ:EXC) last announced its earnings results on Tuesday, November 3rd. The company reported $1.04 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.87 by $0.17. Exelon had a return on equity of 9.24% and a net margin of 7.15%. The business had revenue of $8.85 billion during the quarter, compared to analyst estimates of $8.62 billion. On average, sell-side analysts expect that Exelon Co. will post 3.1 EPS for the current year.
Exelon Corporation, a utility services holding company, engages in the generation and marketing of energy in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, biomass, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services.
See Also: Net Income
Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NASDAQ:EXC).
Receive News & Ratings for Exelon Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Exelon and related companies with MarketBeat.com’s FREE daily email newsletter.